260 related articles for article (PubMed ID: 34232746)
1. Diseases caused by mutations in the Na
Biondo ED; Spontarelli K; Ababioh G; Méndez L; Artigas P
Am J Physiol Cell Physiol; 2021 Aug; 321(2):C394-C408. PubMed ID: 34232746
[TBL] [Abstract][Full Text] [Related]
2. Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability.
Schlingmann KP; Bandulik S; Mammen C; Tarailo-Graovac M; Holm R; Baumann M; König J; Lee JJY; Drögemöller B; Imminger K; Beck BB; Altmüller J; Thiele H; Waldegger S; Van't Hoff W; Kleta R; Warth R; van Karnebeek CDM; Vilsen B; Bockenhauer D; Konrad M
Am J Hum Genet; 2018 Nov; 103(5):808-816. PubMed ID: 30388404
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
Beuschlein F; Boulkroun S; Osswald A; Wieland T; Nielsen HN; Lichtenauer UD; Penton D; Schack VR; Amar L; Fischer E; Walther A; Tauber P; Schwarzmayr T; Diener S; Graf E; Allolio B; Samson-Couterie B; Benecke A; Quinkler M; Fallo F; Plouin PF; Mantero F; Meitinger T; Mulatero P; Jeunemaitre X; Warth R; Vilsen B; Zennaro MC; Strom TM; Reincke M
Nat Genet; 2013 Apr; 45(4):440-4, 444e1-2. PubMed ID: 23416519
[TBL] [Abstract][Full Text] [Related]
4. ATP1A1-linked diseases require a malfunctioning protein product from one allele.
Spontarelli K; Young VC; Sweazey R; Padro A; Lee J; Bueso T; Hernandez RM; Kim J; Katz A; Rossignol F; Turner C; Wilczewski CM; Maxwell GL; Holmgren M; Bailoo JD; Yano ST; Artigas P
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119572. PubMed ID: 37659504
[TBL] [Abstract][Full Text] [Related]
5. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase.
Stindl J; Tauber P; Sterner C; Tegtmeier I; Warth R; Bandulik S
Endocrinology; 2015 Dec; 156(12):4582-91. PubMed ID: 26418325
[TBL] [Abstract][Full Text] [Related]
7. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation.
Stregapede F; Travaglini L; Rebelo AP; Cintra VP; Bellacchio E; Bosco L; Alfieri P; Pro S; Zuchner S; Bertini E; Nicita F
Clin Genet; 2020 Mar; 97(3):521-526. PubMed ID: 31705535
[TBL] [Abstract][Full Text] [Related]
8. Na/K Pump Mutations Associated with Primary Hyperaldosteronism Cause Loss of Function.
Meyer DJ; Gatto C; Artigas P
Biochemistry; 2019 Apr; 58(13):1774-1785. PubMed ID: 30811176
[TBL] [Abstract][Full Text] [Related]
9. On the effect of hyperaldosteronism-inducing mutations in Na/K pumps.
Meyer DJ; Gatto C; Artigas P
J Gen Physiol; 2017 Nov; 149(11):1009-1028. PubMed ID: 29030398
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot-Marie-Tooth disease.
Cinarli Yuksel F; Nicolaou P; Spontarelli K; Dohrn MF; Rebelo AP; Koutsou P; Georghiou A; Artigas P; Züchner SL; Kleopa KA; Christodoulou K
J Neurol; 2023 May; 270(5):2576-2590. PubMed ID: 36738336
[TBL] [Abstract][Full Text] [Related]
11. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2.
Lassuthova P; Rebelo AP; Ravenscroft G; Lamont PJ; Davis MR; Manganelli F; Feely SM; Bacon C; Brožková DŠ; Haberlova J; Mazanec R; Tao F; Saghira C; Abreu L; Courel S; Powell E; Buglo E; Bis DM; Baxter MF; Ong RW; Marns L; Lee YC; Bai Y; Isom DG; Barro-Soria R; Chung KW; Scherer SS; Larsson HP; Laing NG; Choi BO; Seeman P; Shy ME; Santoro L; Zuchner S
Am J Hum Genet; 2018 Mar; 102(3):505-514. PubMed ID: 29499166
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.
Gomez-Sanchez CE; Kuppusamy M; Gomez-Sanchez EP
Mol Cell Endocrinol; 2015 Jun; 408():213-9. PubMed ID: 25496839
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Primary Aldosteronism.
Scholl UI
Hypertension; 2022 May; 79(5):887-897. PubMed ID: 35139664
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity.
Ashmore LJ; Hrizo SL; Paul SM; Van Voorhies WA; Beitel GJ; Palladino MJ
Hum Genet; 2009 Sep; 126(3):431-47. PubMed ID: 19455355
[TBL] [Abstract][Full Text] [Related]
15. Isoform specificity of human Na(+), K(+)-ATPase localization and aldosterone regulation in mouse kidney cells.
Summa V; Camargo SM; Bauch C; Zecevic M; Verrey F
J Physiol; 2004 Mar; 555(Pt 2):355-64. PubMed ID: 14694143
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo.
Barcroft LC; Moseley AE; Lingrel JB; Watson AJ
Mech Dev; 2004 May; 121(5):417-26. PubMed ID: 15147760
[TBL] [Abstract][Full Text] [Related]
17. Neurological disease mutations of α3 Na
Holm R; Toustrup-Jensen MS; Einholm AP; Schack VR; Andersen JP; Vilsen B
Biochim Biophys Acta; 2016 Nov; 1857(11):1807-1828. PubMed ID: 27577505
[TBL] [Abstract][Full Text] [Related]
18. Na,K-ATPase mutations in familial hemiplegic migraine lead to functional inactivation.
Koenderink JB; Zifarelli G; Qiu LY; Schwarz W; De Pont JJ; Bamberg E; Friedrich T
Biochim Biophys Acta; 2005 May; 1669(1):61-8. PubMed ID: 15843000
[TBL] [Abstract][Full Text] [Related]
19.
Kobuke K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Itcho K; Ohno H; Nagano G; Yoshii Y; Baba R; Kodama T; Arihiro K; Hattori N; Yoneda M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681640
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.
Azizan EA; Poulsen H; Tuluc P; Zhou J; Clausen MV; Lieb A; Maniero C; Garg S; Bochukova EG; Zhao W; Shaikh LH; Brighton CA; Teo AE; Davenport AP; Dekkers T; Tops B; Küsters B; Ceral J; Yeo GS; Neogi SG; McFarlane I; Rosenfeld N; Marass F; Hadfield J; Margas W; Chaggar K; Solar M; Deinum J; Dolphin AC; Farooqi IS; Striessnig J; Nissen P; Brown MJ
Nat Genet; 2013 Sep; 45(9):1055-60. PubMed ID: 23913004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
